Toll Free: 1-888-928-9744

Kadmon Corporation, LLC - Product Pipeline Review - 2016

Published: Feb, 2016 | Pages: 47 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Kadmon Corporation, LLC - Product Pipeline Review - 2016

Summary
Global Markets Direct's, 'Kadmon Corporation, LLC - Product Pipeline Review - 2016', provides an overview of the Kadmon Corporation, LLC's pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by Kadmon Corporation, LLC, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data. Scope - The report provides a snapshot of the pipeline therapeutic landscape of Kadmon Corporation, LLC - The report provides overview of Kadmon Corporation, LLC including its business description, key facts, and locations and subsidiaries - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report assesses Kadmon Corporation, LLC's pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type - The report features Kadmon Corporation, LLC's out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects Reasons to buy
- Evaluate Kadmon Corporation, LLC's strategic position with total access to detailed information on its product pipeline - Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for Kadmon Corporation, LLC - Identify potential new clients or partners in the target demographic - Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding Kadmon Corporation, LLC's pipeline depth and focus of pipeline therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
 Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 4 Kadmon Corporation, LLC Snapshot 5 Kadmon Corporation, LLC Overview 5 Key Information 5 Key Facts 5 Kadmon Corporation, LLC - Research and Development Overview 6 Key Therapeutic Areas 6 Kadmon Corporation, LLC - Pipeline Review 9 Pipeline Products by Stage of Development 9 Pipeline Products - Monotherapy 10 Pipeline Products - Partnered Products 11 Partnered Products/Combination Treatment Modalities 12 Kadmon Corporation, LLC - Pipeline Products Glance 13 Kadmon Corporation, LLC - Late Stage Pipeline Products 13 Phase III Products/Combination Treatment Modalities 13 Kadmon Corporation, LLC - Clinical Stage Pipeline Products 14 Phase II Products/Combination Treatment Modalities 14 Phase I Products/Combination Treatment Modalities 15 Kadmon Corporation, LLC - Early Stage Pipeline Products 16 Preclinical Products/Combination Treatment Modalities 16 Discovery Products/Combination Treatment Modalities 17 Kadmon Corporation, LLC - Drug Profiles 18 trientine hydrochloride next generation 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 KD-025 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 KD-026 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 tesevatinib tosylate 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 Gene Therapy to Activate Aquaporin-1 for Xerostomia 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 salirasib 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 KD-033 28 Product Description 28 Mechanism of Action 28 R&D Progress 28 KL-00148 29 Product Description 29 Mechanism of Action 29 R&D Progress 29 KL-00199 30 Product Description 30 Mechanism of Action 30 R&D Progress 30 Monoclonal Antibodies to Inhibit PDL1 for Oncology 31 Product Description 31 Mechanism of Action 31 R&D Progress 31 Monoclonal Antibody to Inhibit VEGFR-2 for Cancer 32 Product Description 32 Mechanism of Action 32 R&D Progress 32 Small Molecules to Inhibit Acetyl-CoA Carboxylase for CMV Infections 33 Product Description 33 Mechanism of Action 33 R&D Progress 33 Kadmon Corporation, LLC - Pipeline Analysis 34 Kadmon Corporation, LLC - Pipeline Products by Target 34 Kadmon Corporation, LLC - Pipeline Products by Route of Administration 36 Kadmon Corporation, LLC - Pipeline Products by Molecule Type 37 Kadmon Corporation, LLC - Pipeline Products by Mechanism of Action 38 Kadmon Corporation, LLC - Recent Pipeline Updates 39 Kadmon Corporation, LLC - Dormant Projects 44 Kadmon Corporation, LLC - Locations And Subsidiaries 45 Head Office 45 Other Locations & Subsidiaries 45 Appendix 46 Methodology 46 Coverage 46 Secondary Research 46 Primary Research 46 Expert Panel Validation 46 Contact Us 46 Disclaimer 47
List of Tables
Kadmon Corporation, LLC, Key Information 5 Kadmon Corporation, LLC, Key Facts 5 Kadmon Corporation, LLC - Pipeline by Indication, 2016 7 Kadmon Corporation, LLC - Pipeline by Stage of Development, 2016 9 Kadmon Corporation, LLC - Monotherapy Products in Pipeline, 2016 10 Kadmon Corporation, LLC - Partnered Products in Pipeline, 2016 11 Kadmon Corporation, LLC - Partnered Products/ Combination Treatment Modalities, 2016 12 Kadmon Corporation, LLC - Phase III, 2016 13 Kadmon Corporation, LLC - Phase II, 2016 14 Kadmon Corporation, LLC - Phase I, 2016 15 Kadmon Corporation, LLC - Preclinical, 2016 16 Kadmon Corporation, LLC - Discovery, 2016 17 Kadmon Corporation, LLC - Pipeline by Target, 2016 34 Kadmon Corporation, LLC - Pipeline by Route of Administration, 2016 36 Kadmon Corporation, LLC - Pipeline by Molecule Type, 2016 37 Kadmon Corporation, LLC - Pipeline Products by Mechanism of Action, 2016 38 Kadmon Corporation, LLC - Recent Pipeline Updates, 2016 39 Kadmon Corporation, LLC - Dormant Developmental Projects,2016 44 Kadmon Corporation, LLC, Other Locations 45 Kadmon Corporation, LLC, Subsidiaries 45



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify